ZA986330B - Medicaments comprising at least one substituted derivative of polyhydroxyalkypyrazines new derivatives and their preparation. - Google Patents

Medicaments comprising at least one substituted derivative of polyhydroxyalkypyrazines new derivatives and their preparation.

Info

Publication number
ZA986330B
ZA986330B ZA986330A ZA986330A ZA986330B ZA 986330 B ZA986330 B ZA 986330B ZA 986330 A ZA986330 A ZA 986330A ZA 986330 A ZA986330 A ZA 986330A ZA 986330 B ZA986330 B ZA 986330B
Authority
ZA
South Africa
Prior art keywords
substituents
chain
polyhydroxyalkypyrazines
medicaments
preparation
Prior art date
Application number
ZA986330A
Other languages
English (en)
Inventor
Herve Bouchard
Alain Commercon
Jean-Francois Peyronel
Corinne Terrier
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA986330B publication Critical patent/ZA986330B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA986330A 1997-07-18 1998-07-16 Medicaments comprising at least one substituted derivative of polyhydroxyalkypyrazines new derivatives and their preparation. ZA986330B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9709186A FR2766185B1 (fr) 1997-07-18 1997-07-18 Medicaments contenant en tant que principe actif au moins un derive substitue de polyhydroxylalkylpyrazines, les nouveaux derives polyhydroxylalkylpyrazines et leur preparation

Publications (1)

Publication Number Publication Date
ZA986330B true ZA986330B (en) 1999-02-08

Family

ID=9509395

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA986330A ZA986330B (en) 1997-07-18 1998-07-16 Medicaments comprising at least one substituted derivative of polyhydroxyalkypyrazines new derivatives and their preparation.

Country Status (12)

Country Link
US (1) US6380197B1 (de)
EP (1) EP1001943B1 (de)
JP (1) JP4443035B2 (de)
AT (1) ATE256668T1 (de)
AU (1) AU8810598A (de)
DE (1) DE69820634T2 (de)
DK (1) DK1001943T3 (de)
ES (1) ES2209186T3 (de)
FR (1) FR2766185B1 (de)
PT (1) PT1001943E (de)
WO (1) WO1999003843A1 (de)
ZA (1) ZA986330B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788274B1 (fr) * 1999-01-11 2001-02-09 Aventis Pharma Sa Nouveaux derives de polyhydroxypyrazines, leur preparation et les compositions pharmaceutiques qui les contiennent
KR20090095626A (ko) 2006-12-04 2009-09-09 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 쿠프레독신과 ＣｐＧ 리치 ＤＮＡ를 이용한 조성물 및 암 치료 방법
US8011596B2 (en) * 2008-02-13 2011-09-06 Hand Held Products, Inc. Machine readable 2D symbology printable on demand
KR20220051164A (ko) 2019-07-05 2022-04-26 아이오엠엑스 테라퓨틱스 아게 Igsf11 (vsig3)의 항체 결합 igc2 및 이의 용도
WO2022008027A1 (en) 2020-07-06 2022-01-13 Iomx Therapeutics Ag Antibodies binding igv of igsf11 (vsig3) and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3443141B2 (ja) * 1993-10-05 2003-09-02 株式会社リコー 画像傾き検出方法及び表処理方法
FR2744365B1 (fr) 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Also Published As

Publication number Publication date
DE69820634D1 (de) 2004-01-29
JP2001510187A (ja) 2001-07-31
JP4443035B2 (ja) 2010-03-31
ES2209186T3 (es) 2004-06-16
AU8810598A (en) 1999-02-10
DE69820634T2 (de) 2004-10-21
ATE256668T1 (de) 2004-01-15
EP1001943A1 (de) 2000-05-24
US6380197B1 (en) 2002-04-30
FR2766185B1 (fr) 2001-06-15
WO1999003843A1 (fr) 1999-01-28
PT1001943E (pt) 2004-07-30
FR2766185A1 (fr) 1999-01-22
EP1001943B1 (de) 2003-12-17
DK1001943T3 (da) 2004-03-29

Similar Documents

Publication Publication Date Title
FI934626A0 (fi) Substituerade bensylaminokinuklidiner
PH31064A (en) Polymers containing diester units.
ES2164110T3 (es) Usos farmaceuticos de derivados de esteroides.
ATE133165T1 (de) Aza-macrozyklen und verfahren zu deren herstellung
FR2379553A1 (fr) Nouveaux photoinducteurs de polymerisation, compositions photopolymerisables les contenant et procede de photopolymerisation
MY103905A (en) Aminoalkoxyphenyl derivatives, process of preparation and compositions containing the same.
MY105538A (en) Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them.
AU8810598A (en) Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them
CA2334563A1 (en) Use of 2,2,6,6 tetraalkylpiperidine-n-oxyl radicals having long alkyl chains as polymerization regulators
MX9700807A (es) Derivados de 3-azabiciclo (3.2.0)heptano n-sustituidos utiles como neurolepticos.
FR2400008A1 (fr) Agents anti-hypertensifs
DE3067006D1 (en) Insecticides and piperidine derivative
DE69818679D1 (de) Pyrazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
BG61811B1 (en) Preparation for plant disease control
AU8460791A (en) Compound, preparation and use
MY104777A (en) Benzoxazine dyes
ATE30159T1 (de) Anthracyclinderivate, verfahren zu ihrer herstellung ausgehend von einem stamm von mikroorganismen, der neue stamm streptomyces cyaneus und die verwendung der anthracyclinderivate als pharmazeutische praeparate.
FR2378518A1 (fr) Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne
GR1001566B (el) Μέ?οδος παρασκευής νέων παραγώγων βενζοφουρανυλιμιδαζόλης.
AU5241490A (en) Platinum complexes and antitumor agents containing them as an active ingredient
ES535903A0 (es) Procedimiento de preparacion de derivados de nitrosoureas
DE69601451D1 (de) UCK14-Verbindungen
AU1675692A (en) Medicaments containing azacyclodiphosphonic acid derivatives, novel azacyclodiphosphonic acid derivatives and process for producing them
ES473733A1 (es) Procedimiento de preparacion de nuevos bis-tioaralcohil-al- cohil-alcohil-boranos
TW360627B (en) Cyclopentadienyl derivatives and process for the preparation